Table 1

Characteristics of 78 eligible patients treated with RABVD

CharacteristicRABVD
Total, N78
Sex, n (%)
    Male40 (51)
    Female38 (49)
Median age, y (range)32 (18-72)
Stage, n (%)
    II28 (36)
        > 8 cm with B symptoms3 (4)
        ≥ 10 cm or mediastinal ≥ 1/3 chest diameter23 (29)
         Relapsed after previous primary radiation therapy2 (3)
    III24 (31)
    IV26 (33)
IPS, n (%)
    06 (8)
    119 (24)
    218 (23)
    318 (23)
    ≥ 417 (22)
CD20 status, n (%)
    Positive14 (18)
    Negative56 (72)
    Unknown8 (10)
Postchemotherapy radiation, n (%)26 (33)